Entheon Announces Change of Directors
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF) has announced a change in its Board of Directors. Harrison Newlands has been appointed to the board effective April 3, 2025, while Andrew Hegle has resigned.
Newlands brings nearly a decade of experience in start-ups and capital markets. His notable achievements include co-founding Fire & Flower, a Canadian retail cannabis company, where he served as Director of Business Development. He also co-founded Hoshi International, a medicinal cannabis producer in Portugal, and Hypercharge Networks, Canada's first publicly traded EV charging company.
His career began as a Research Associate at MacNicol and Associates on Bay Street. He has also served as a strategic advisor for Taiga Motors, was formerly a partner at Rockbank Capital, and currently serves as a managing partner at North King Capital, where he advises public and private companies.
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF) ha annunciato un cambiamento nel suo Consiglio di Amministrazione. Harrison Newlands è stato nominato membro del consiglio a partire dal 3 aprile 2025, mentre Andrew Hegle si è dimesso.
Newlands porta con sé quasi un decennio di esperienza nel settore delle start-up e dei mercati dei capitali. Tra i suoi risultati più significativi c'è la co-fondazione di Fire & Flower, un'azienda canadese di cannabis al dettaglio, dove ha ricoperto il ruolo di Direttore dello Sviluppo Commerciale. Ha anche co-fondato Hoshi International, un produttore di cannabis medicinale in Portogallo, e Hypercharge Networks, la prima azienda canadese di ricarica per veicoli elettrici quotata in borsa.
La sua carriera è iniziata come Ricercatore Associato presso MacNicol and Associates in Bay Street. Ha anche ricoperto il ruolo di consulente strategico per Taiga Motors, è stato precedentemente partner di Rockbank Capital e attualmente è partner gestore di North King Capital, dove consiglia aziende pubbliche e private.
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF) ha anunciado un cambio en su Junta Directiva. Harrison Newlands ha sido nombrado para la junta a partir del 3 de abril de 2025, mientras que Andrew Hegle ha renunciado.
Newlands aporta casi una década de experiencia en startups y mercados de capitales. Sus logros notables incluyen la co-fundación de Fire & Flower, una empresa canadiense de cannabis minorista, donde se desempeñó como Director de Desarrollo Comercial. También co-fundó Hoshi International, un productor de cannabis medicinal en Portugal, y Hypercharge Networks, la primera empresa canadiense de carga de vehículos eléctricos que cotiza en bolsa.
Su carrera comenzó como Asociado de Investigación en MacNicol and Associates en Bay Street. También ha sido asesor estratégico para Taiga Motors, fue anteriormente socio en Rockbank Capital y actualmente es socio gerente en North King Capital, donde asesora a empresas públicas y privadas.
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF)는 이사회의 변화를 발표했습니다. Harrison Newlands는 2025년 4월 3일부터 이사로 임명되었으며, Andrew Hegle는 사임했습니다.
Newlands는 스타트업 및 자본 시장에서 거의 10년의 경험을 가지고 있습니다. 그의 주요 성과 중 하나는 캐나다 소매 대마초 회사인 Fire & Flower의 공동 설립으로, 이곳에서 사업 개발 이사로 근무했습니다. 그는 또한 포르투갈의 의약용 대마초 생산업체인 Hoshi International와 캐나다 최초의 상장 전기차 충전 회사인 Hypercharge Networks를 공동 설립했습니다.
그의 경력은 Bay Street의 MacNicol and Associates에서 연구원으로 시작되었습니다. 그는 Taiga Motors의 전략 고문으로도 활동했으며, Rockbank Capital의 파트너였고 현재는 North King Capital의 관리 파트너로서 공공 및 민간 기업에 조언하고 있습니다.
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF) a annoncé un changement au sein de son Conseil d'Administration. Harrison Newlands a été nommé membre du conseil à compter du 3 avril 2025, tandis qu'Andrew Hegle a démissionné.
Newlands apporte près d'une décennie d'expérience dans les start-ups et les marchés de capitaux. Parmi ses réalisations notables, il a co-fondé Fire & Flower, une entreprise canadienne de cannabis de détail, où il a occupé le poste de Directeur du Développement Commercial. Il a également co-fondé Hoshi International, un producteur de cannabis médical au Portugal, et Hypercharge Networks, la première entreprise canadienne de recharge de véhicules électriques cotée en bourse.
Sa carrière a débuté en tant qu'Associé de Recherche chez MacNicol and Associates sur Bay Street. Il a également été conseiller stratégique pour Taiga Motors, a été partenaire chez Rockbank Capital et est actuellement partenaire gérant chez North King Capital, où il conseille des entreprises publiques et privées.
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF) hat eine Änderung in seinem Vorstand bekannt gegeben. Harrison Newlands wurde mit Wirkung zum 3. April 2025 in den Vorstand berufen, während Andrew Hegle zurückgetreten ist.
Newlands bringt fast ein Jahrzehnt Erfahrung in Start-ups und Kapitalmärkten mit. Zu seinen bemerkenswerten Leistungen gehört die Mitbegründung von Fire & Flower, einem kanadischen Einzelhandelsunternehmen für Cannabis, wo er als Direktor für Geschäftsentwicklung tätig war. Er war auch Mitbegründer von Hoshi International, einem Produzenten von medizinischem Cannabis in Portugal, und Hypercharge Networks, dem ersten an der Börse notierten Unternehmen für Elektrofahrzeug-Ladestationen in Kanada.
Seine Karriere begann als Forschungsassistent bei MacNicol and Associates in der Bay Street. Er war auch strategischer Berater für Taiga Motors, war früher Partner bei Rockbank Capital und ist derzeit Managing Partner bei North King Capital, wo er öffentliche und private Unternehmen berät.
- Appointment of experienced director with extensive cannabis industry expertise
- New director brings strong background in capital markets and start-up development
- Addition of director with successful track record in founding and scaling companies
- Loss of existing board member Andrew Hegle
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands to the Company's Board of Directors, effective April 3, 2025.
Harrison Newlands has a diverse understanding of start-ups and capital markets, having invested, advised, and helped co-found dozens of mid-cap companies spanning close to a decade of experience in the industry. He started his career working on Bay Street as a Research Associate at MacNicol and Associates, thereafter he jumped into the fast growing cannabis industry, and was one of the co-founders of Fire & Flower, one of Canada's first retail focused cannabis companies, where he led its early growth and served as Director of Business Development. Shortly thereafter, he helped take the first EV company public in Canada, Taiga Motors, where he served as a strategic advisor.
Mr. Newlands also co-founded Hoshi International, a producer of medicinal cannabis with a state of the art facility in Portugal, focusing on the emerging European market. Harrison also co-founded Hypercharge Networks, Canada's first publicly traded EV charging company. Harrison was formerly a partner at Rockbank Capital, a Vancouver based merchant bank, and has been a managing partner at North King Capital over the past 4 years, where he continues to advise both public and private companies, as well as invest.
Andrew Hegle has resigned from the Company's Board of Directors. The Company wishes to thank Mr. Hegle for his services and wishes him all the best in future endeavours.
About Entheon Biomedical Corp.
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.
On Behalf of the Board of Directors,
Timothy Ko, CEO, President and Director
For more information, please contact the Company at:
Entheon Biomedical Corp.
Timothy Ko, CEO
1 (604) 562-3932
timothy@entheonbiomedical.com
https://entheonbiomedical.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247466
FAQ
When did Harrison Newlands join Entheon Biomedical's (ENTBF) Board of Directors?
What is Harrison Newlands' experience in the cannabis industry for ENTBF?
Which board member resigned from Entheon Biomedical (ENTBF)?
What are Harrison Newlands' current business activities related to ENTBF?
